The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China.
The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China; Department of Biomedical Engineering, School of Material Science and Engineering, South China University of Technology, Guangzhou, China.
J Psychiatr Res. 2021 Dec;144:312-319. doi: 10.1016/j.jpsychires.2021.10.037. Epub 2021 Oct 23.
Ketamine has rapid and robust antidepressant effects in depression, while its effects on cognitive measures are less clearly understood. This aim of the study herein is to determine whether ketamine has direct pro-cognitive effects in real-world treatment depression and/or suicidality.
Subjects with unipolar (n = 84) and bipolar (n = 27) depression suffering treatment resistance or suicidality received six infusions of ketamine (0.5 mg/kg) during a 12-day period. Depression symptoms were assessed using the Montgomery-Asberg Depression Rating Scale at baseline, day 13 and day 26. Cognitive domains, including processing speed, working memory, visual learning and verbal learning were also measured using the MATRICS Consensus Cognitive Battery at the same time-points.
Significant improvement was observed in processing speed at day 13 (effect size [ES] = 0.501) and day 26 (ES = 0.654), and verbal learning at day 13 (ES = 0.362). Path analysis showed significant direct (β = 2.444, P = 0.017) and indirect (β = 1.220, P = 0.048) effect of ketamine on processing speed, indicating its improvement was partly independent of improvement in depressive symptoms. The direct effect (β = -1.963, P = 0.052) of ketamine on verbal learning was not significant, whereas the indirect effect (β = 1.386, P = 0.024) was significant, indicating treatment with ketamine indirectly improved verbal learning performance, via changes in depressive symptom.
Six infusions of ketamine have a potential mood independent pro-cognitive effect on processing speed in adults with treatment depression and/or suicidality. The potential pro-cognitive effects of ketamine provide the basis for hypothesizing that other clinical outcomes (e.g., suicidality, functional impairment) reported with ketamine treatment may be in part mediated by improvement in cognition.
氯胺酮在抑郁症中具有快速而强大的抗抑郁作用,但其对认知测量的影响则不太清楚。本研究旨在确定氯胺酮在现实世界的抑郁症和/或自杀治疗中是否具有直接的认知增强作用。
患有单相(n=84)和双相(n=27)抑郁症的患者,且存在治疗抵抗或自杀倾向,在 12 天内接受了 6 次氯胺酮(0.5mg/kg)输注。在基线、第 13 天和第 26 天,使用蒙哥马利-阿斯伯格抑郁评定量表评估抑郁症状。在同一时间点,还使用 MATRICS 共识认知电池测量认知域,包括加工速度、工作记忆、视觉学习和言语学习。
在第 13 天(效应量 [ES] = 0.501)和第 26 天(ES = 0.654)观察到加工速度显著改善,在第 13 天(ES = 0.362)观察到言语学习改善。路径分析显示,氯胺酮对加工速度具有显著的直接(β=2.444,P=0.017)和间接(β=1.220,P=0.048)作用,表明其改善部分独立于抑郁症状的改善。氯胺酮对言语学习的直接效应(β=-1.963,P=0.052)不显著,而间接效应(β=1.386,P=0.024)显著,表明氯胺酮治疗通过改变抑郁症状,间接地改善了言语学习表现。
6 次氯胺酮输注对有治疗抑郁症和/或自杀倾向的成年人的加工速度具有潜在的、不依赖于情绪的认知增强作用。氯胺酮的潜在认知增强作用为假设提供了依据,即氯胺酮治疗报告的其他临床结果(例如,自杀倾向、功能障碍)可能部分是通过认知改善介导的。